Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:14 (5 January), doi:10.1136/bmj.39428.617431.DB
Annabel Ferriman
1 BMJ
| The first 150 words of the full text of this article appear below. |
The Royal College of Physicians has set up a joint working party with the drug industry to try to create a better relationship between doctors and drug companies, so as to improve the care of patients.
The group, chaired by Richard Horton, editor of the Lancet, is taking oral evidence from doctors and academics and representatives of the industry, medical journals, and regulators. It has also asked interested parties to submit written evidence by 31 March.
In a letter inviting submissions Dr Horton and Ian Gilmore, the colleges president, say: "There are barriers perceived to exist between the industry, the NHS and academic medicine that inhibit a truly dynamic and productive relationship between the key players, working in the best interests of patients.
"The Royal College of Physicians identified a need to look into this relationship and to examine in some detail the political, economic, commercial, organisational, professional and
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses